| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
3'-Amino-3'-deoxy-5-methyluridine manufacturers
|
| | 3'-Amino-3'-deoxy-5-methyluridine Basic information |
| Product Name: | 3'-Amino-3'-deoxy-5-methyluridine | | Synonyms: | 3'-Amino-3'-deoxy-5-methyluridine;3’-Amino-3’-deoxy-5-methyl uridine, Anticancer antiviral agent;Uridine, 3'-amino-3'-deoxy-5-methyl- (6CI,9CI);3’-Amino-3’-deoxy-5-methyluridine;1-((2R,3R,4S,5S)-4-amino-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione | | CAS: | 108630-07-5 | | MF: | C10H15N3O5 | | MW: | 257.24 | | EINECS: | | | Product Categories: | | | Mol File: | 108630-07-5.mol |  |
| | 3'-Amino-3'-deoxy-5-methyluridine Chemical Properties |
| Melting point | 223-225 °C | | density | 1.475±0.06 g/cm3(Predicted) | | pka | 9.55±0.10(Predicted) |
| | 3'-Amino-3'-deoxy-5-methyluridine Usage And Synthesis |
| Uses | 3’-Amino-3’-deoxy-5-methyl uridine, Anticancer antiviral agent is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 3'-Amino-3'-deoxy-5-methyluridine Preparation Products And Raw materials |
|